Stifel analyst Nathan Jones maintains $IDEX Corp (IEX.US)$ with a buy rating, and maintains the target price at $244.
According to TipRanks data, the analyst has a success rate of 67.3% and a total average return of 18.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $IDEX Corp (IEX.US)$'s main analysts recently are as follows:
Idex Corp.'s recent earnings outperformance is noted alongside a slight operating income surpassing expectations. The company has also raised the lower end of its 2024 guidance. A key factor contributing to the stock's positive movement is the reported stabilization within the life sciences area of the Health & Science Technologies segment, following an extended phase of inventory reduction and sluggishness.
Analysts noted that Idex Corp.'s third-quarter results were operationally consistent with expectations, as gains in the FSDP segment helped to balance out weaker performance in the FMT division. The company's guidance for 2024 was increased at the lower end, aligning with general consensus. Encouraging signs include the stabilization hinted at by daily order rates, demand commentary, and estimates, especially after a challenging time for the company.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
斯迪富分析師Nathan Jones維持$IDEX Corp (IEX.US)$買入評級，維持目標價244美元。
根據TipRanks數據顯示，該分析師近一年總勝率為67.3%，總平均回報率為18.0%。
此外，綜合報道，$IDEX Corp (IEX.US)$近期主要分析師觀點如下：
Idex Corp. '其最近的收益表現優於預期，營業收入略有超出預期。該公司還提高了其2024年指引的下限。促成該股積極走勢的一個關鍵因素是，據報道，在經歷了長時間的庫存減少和疲軟之後，健康與科學技術板塊的生命科學領域趨於穩定。
分析師指出，Idex Corp. '由於FSDP板塊的漲勢有助於平衡fMT部門的疲軟表現，其第三季度業績在運營上與預期一致。該公司對2024年的低端預期有所提高，這與普遍共識一致。令人鼓舞的跡象包括每日訂單率、需求評論和估計所暗示的穩定，尤其是在公司經歷了艱難時期之後。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
